Back to Search
SERGIO GIRALT, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1639278880IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
259157(NY)
Education
OTHER
Class of 1984
Research & Publications (20)
CR represents an early index of potential long survival in multiple myeloma.
PMID 19633690·Bone Marrow Transplant·2010
8-other
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.
PMID 19668237·Bone Marrow Transplant·2010
3-trial
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).
PMID 19554029·Leukemia·2009
6-review
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma.
PMID 19384931·Am J Hematol·2009
8-other
Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes.
PMID 19361753·Biol Blood Marrow Transplant·2009
2-rct
Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.
PMID 19535777·J Natl Cancer Inst·2009
8-other
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.
PMID 19494840·Leukemia·2009
6-review
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.
PMID 19168784·Blood·2009
8-other
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
PMID 19450756·Biol Blood Marrow Transplant·2009
8-other
Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation.
PMID 19589479·Biol Blood Marrow Transplant·2009
4-observational
Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.
PMID 19539212·Biol Blood Marrow Transplant·2009
3-trial
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia.
PMID 19235255·Cancer·2009
8-other
Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research.
PMID 19203728·Biol Blood Marrow Transplant·2009
8-other
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.
PMID 19654407·Blood·2009
8-other
Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience.
PMID 19571599·Oncology·2009
8-other
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome.
PMID 19151791·Bone Marrow Transplant·2009
3-trial
Allografting older patients--myths and realities.
PMID 19147096·Biol Blood Marrow Transplant·2009
6-review
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
PMID 19144658·Haematologica·2009
8-other
Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
PMID 19135949·Biol Blood Marrow Transplant·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE, BOX 235
NEW YORK, NY 10065 - Phone
- (212) 639-6009
Quick Facts
- NPI
- 1639278880
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile